Cytomegalovirus disease in children with acute lymphoblastic leukemia

References

• Lund B, Åsberg A, Heyman M, et al. Nordic Society of Paediatric Haematology and Oncology. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2011;56:551–559.
   PubMedGoogle Scholar
• Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012;30:1663–1669.
   PubMed Web of Science ®Google Scholar
• Marwaha RK, Kulkarni KP, Bansal D, Trehan A. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India. J Pediatr Hematol Oncol. 2010;32:366–369.
   PubMed Web of Science ®Google Scholar
• Rajajee S, Desikulu MV, Pushpa V. Survival of childhood acute lymphoblastic leukemia: experience in Chennai. J Trop Pediatr. 1999;45:367–370.
   PubMed Web of Science ®Google Scholar
• Lehrnbecher T, Phillips R, Alexander S, et al. International Pediatric Fever and Neutropenia Guideline Panel. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation. J Clin Oncol. 2012;30:4427–4438.
   PubMed Web of Science ®Google Scholar
• Pass RF. Cytomegalovirus. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practices of Pediatric Infectious Disease. 3rd ed. Philadelphia: Churchill Livingstone; 2008:1029–1035.
   Google Scholar
• Science M, Robinson PD, MacDonald T, et al. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients. Pediatr Blood Cancer. 2014;61:393–400.
   PubMed Web of Science ®Google Scholar
• Averbuch D, Orasch C, Cordonnier C, et al. ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98:1826–1835.
   PubMed Web of Science ®Google Scholar
• Ammann RA, Tissing WJ, Phillips B. Rationalizing the approach to children with fever in neutropenia. Curr Opin Infect Dis. 2012;25:258–265.
   PubMed Web of Science ®Google Scholar
• Eyrich M, Wiegering V, Lim A, et al. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia—a prospective study of 20 paediatric patients. Br J Haematol. 2009;147:360–370.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52:e56–e93.
   Google Scholar
• Han XY. Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Microbiol. 2007;45:1126–1132.
   PubMed Web of Science ®Google Scholar
• Nguyen DD, Cao TM, Dugan K, et al. Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia. Clin Lymphoma. 2002;3:105–110.
   PubMedGoogle Scholar
• Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094–1097.
   PubMed Web of Science ®Google Scholar
• Venkitaraman AR, Seigneurin JM, Lenoir GM, John TJ. Infections due to the human herpesviruses in southern India: a seroepidemiological survey. Int J Epidemiol. 1986;15:561–566.
   PubMed Web of Science ®Google Scholar
• Chemaly RF, Torres HA, Hachem RY, et al. Cytomegalovirus pneumonia in patients with lymphoma. Cancer. 2005;104:1213–1220.
   PubMed Web of Science ®Google Scholar
• Capria S, Gentile G, Capobianchi A, et al. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia. J Med Virol. 2010;82:1201–1207.
   PubMed Web of Science ®Google Scholar
• Luczynski W, Stasiak-Barmuta A, Krawczuk-Rybak M. Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report. Pediatr Blood Cancer. 2004;42:416–420.
   PubMed Web of Science ®Google Scholar
• El-Chennawi FA, Al-Tonbary YA, Mossad YM, Ahmed MA. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection. Hematology. 2008;13:203–209.
   PubMed Web of Science ®Google Scholar
• Lovat PE, Robinson JH, Windebank KP, Kernahan J, Watson JG. Serial study of T lymphocytes in childhood leukemia during remission. Pediatr Hematol Oncol. 1993;10:129–139.
   PubMed Web of Science ®Google Scholar
• Ng AP, Worth L, Chen L, et al. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. Haematologica. 2005;90:1672–1679.
   PubMed Web of Science ®Google Scholar
• Gulia S, Dangi U, Biswas S, et al. Prevalence and patterns of cytomegalovirus DNAemia in adult patients with acute lymphoblastic leukemia on chemotherapy. Leuk Lymphoma. 2014;55:1209–1211.
   PubMed Web of Science ®Google Scholar
• Rahbarimanesh A, Ehsani M, Karahroudi M, et al. Cytomegalovirus disease in children with acute lymphoblastic leukemia in the nontransplant setting: case series and review of the literature. J Pediatr Hematol Oncol. 2015;37:429–432.
   PubMed Web of Science ®Google Scholar
• Kanvinde S, Bhargava P, Patwardhan S. Cytomegalovirus infection as a cause of cytopenia after chemotherapy for hematological malignancies. Indian Pediatr. 2013;50:197–201.
   PubMed Web of Science ®Google Scholar
• Torres HA, Aguilera E, Safdar A, et al. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect. 2008;14:1160–1166.
   PubMed Web of Science ®Google Scholar
• Nierenberg NE, Poutsiaka DD, Chow JK, et al. Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation. Liver Transpl. 2014;20:1497–1507.
   PubMed Web of Science ®Google Scholar